- Home
- MREO vs OGI Comparison
MREO vs OGI Comparison
Compare MREO & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- OGI
- Stock Information
- Founded
- MREO 2015
- OGI 2013
- Country
- MREO United Kingdom
- OGI Canada
- Employees
- MREO N/A
- OGI N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- OGI Biotechnology: Pharmaceutical Preparations
- Sector
- MREO Health Care
- OGI Health Care
- Exchange
- MREO Nasdaq
- OGI Nasdaq
- Market Cap
- MREO 281.6M
- OGI 231.9M
- IPO Year
- MREO N/A
- OGI N/A
- Fundamental
- Price
- MREO $1.79
- OGI $1.64
- Analyst Decision
- MREO Strong Buy
- OGI
- Analyst Count
- MREO 5
- OGI 0
- Target Price
- MREO $7.40
- OGI N/A
- AVG Volume (30 Days)
- MREO 1.2M
- OGI 1.1M
- Earning Date
- MREO 08-12-2025
- OGI 08-13-2025
- Dividend Yield
- MREO N/A
- OGI N/A
- EPS Growth
- MREO N/A
- OGI N/A
- EPS
- MREO N/A
- OGI 0.05
- Revenue
- MREO $500,000.00
- OGI $164,107,753.00
- Revenue This Year
- MREO N/A
- OGI $58.15
- Revenue Next Year
- MREO $55.50
- OGI $14.60
- P/E Ratio
- MREO N/A
- OGI $32.37
- Revenue Growth
- MREO N/A
- OGI 50.01
- 52 Week Low
- MREO $1.47
- OGI $0.85
- 52 Week High
- MREO $4.72
- OGI $2.00
- Technical
- Relative Strength Index (RSI)
- MREO 52.86
- OGI 56.79
- Support Level
- MREO $1.68
- OGI $1.56
- Resistance Level
- MREO $1.83
- OGI $1.78
- Average True Range (ATR)
- MREO 0.08
- OGI 0.08
- MACD
- MREO 0.03
- OGI -0.00
- Stochastic Oscillator
- MREO 82.61
- OGI 57.58
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.